RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44-EGFR

Laboratory Investigation

Volumn 91, Issue 3, 2011, Pages 379-391

  Hatano, Hiroko ^a   Shigeishi, Hideo ^a   Kudo, Yasusei ^a   Higashikawa, Koichiro ^a   Tobiume, Kei ^a   Takata, Takashi ^a   Kamata, Nobuyuki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

cementifying fibroma; EGFR; epiregulin; hyaluronan; RHAMM

Indexed keywords

AURORA A KINASE; CELL PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIREGULIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HERMES ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PROTEIN RHAMM; RAF PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; CELL CYCLE; CELL GROWTH; CELL IMMORTALIZATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FIBROMA; HUMAN; HUMAN CELL; JAW; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANTIGENS, CD44; CELL CYCLE PROTEINS; CELL LINE, TRANSFORMED; CELL NUCLEUS; CELL PROLIFERATION; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR MATRIX PROTEINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROMA, OSSIFYING; GENE EXPRESSION PROFILING; GENE SILENCING; HUMANS; HYALURONIC ACID; LIGANDS; MICROTUBULE-ASSOCIATED PROTEINS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 79952088448     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.176     Document Type: Article

References (43)

1. Kramer IR, Pindborg JJ, Shear M. The WHO histological typing of odontogenic tumours. A commentary on the Second Edition. Cancer 1992;70:2988-2994.
2. Slootweg PJ. Osseous dysplasia, WHO classification of tumours. In: Barnes L, Eveson JW, Reichart, P et al. Pathology and Genetics, Head and Neck Tumours. IARC press: Lyon, 2005; 323.
3. Kudo Y, Hiraoka M, Kitagawa S, et al. Establishment of human cementifying fibroma cell lines by transfection with temperaturesensitive simian virus-40 T-antigen gene and hTERT gene. Bone 2002;30:712-717. (Pubitemid 34467992)
4. Wang C, Entwistle J, Hou G, et al. The characterization of a human RHAMM cDNA: conservation of the hyaluronan-binding domains. Gene 1996;174:299-306. (Pubitemid 26340811)
5. Hardwick C, Hoare K, Owens R, et al. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol 1992;117:1343-1350.
6. Assmann V, Jenkinson D, Marshall JF, et al. The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments. J Cell Sci 1999;112:3943-3954. (Pubitemid 30119764)
7. Turley EA, Noble PW, Bourguignon LY, et al. Signaling properties of hyaluronan receptors. J Biol Chem 2002;277:4589-4592. (Pubitemid 34968484)
8. Bajorath J, Greenfield B, Munro SB, et al. Identification of CD44 residues important for hyaluronan binding and delineation of the binding site. J Biol Chem 1998;273:338-343. (Pubitemid 28042214)
9. Entwistle J, Hall CL, Turley EA, et al. HA receptors: regulators of signalling to the cytoskeleton. J Cell Biochem 1996;61:569-577. (Pubitemid 26240134)
10. Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789-801. (Pubitemid 29234556)
11. Laurent TC, Fraser JR. Hyaluronan. FASEB 1992;J6:2397-2404.
12. Kawasaki K, Ochi M, Uchio Y, et al. Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels. J Cell Physiol 1999;179:142-148. (Pubitemid 29165142)
13. Yoneda M, Suzuki S, Kimata K, et al. Hyaluronic acid associated with the surfaces of cultured fibroblasts is linked to a serum-derived 85-kDa protein. J Biol Chem 1990;265:5247-5257.
14. Mahadevan P, Larkins RG, Fraser JR, et al. Effect of prostaglandin E2 and hyaluronan on mesangial cell proliferation. A potential contribution to glomerular hypercellularity in diabetes. Diabetes 1996;45:44-50. (Pubitemid 26010421)
15. Goebeler M, Kaufmann D, Brocker EB, et al. Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors. J Cell Sci 1996;109:957-1964.
16. Kothapalli D, Flowers J, Xu T, et al. Differential activation of ERK and Rac mediates the proliferative and anti-proliferative effects of hyaluronan and CD44. J Biol Chem 2008;283:31823-31829.
17. Savani RC, Wang C, Yang B, et al. Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J Clin Invest 1995;95:1158-1168.
18. Pilarski LM, Miszta H, Turley EA. Regulated expression of a receptor for hyaluronan-mediated motility on human thymocytes and T cells. J Immunol 1993;150:4292-4302. (Pubitemid 23133705)
19. Hall CL, Wang C, Lange LA, et al. Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J Cell Biol 1994;126:575-588. (Pubitemid 24226272)
20. Zang S, Chang MD, Zylka D, et al. The hyaluronan receptor RHAMM regulates extracellular regulated kinase. J Biol Chem 1998;273: 11342-11348. (Pubitemid 28204989)
21. Hall CL, Yang B, Yang X, et al. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell 1995;82:19-26.
22. Shigeishi H, Fujimoto S, Hiraoka M, et al. Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas. Int J Oncol 2009;34:1565-1571.
23. Crainie M, Belch AR, Mant MJ, et al. Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM variants. Blood 1999;93:1684-1696. (Pubitemid 29102497)
24. Teder P, Bergh J, Heldin P. Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines. Cancer Res 1995;55:3908-3914.
25. Gust KM, Hofer MD, Perner SR, et al. RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease. Neoplasia 2009;11: 956-963.
26. Maxwell CA, Keats JJ, Belch AR, et al. Receptor for hyaluronanmediated motility correlates with centrosome abnormalities in multiple myeloma and maintains mitotic integrity. Cancer Res 2005;65:850-860. (Pubitemid 40216444)
27. Tsai MY, Wiese C, Cao K, et al. A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assembly. Nat Cell Biol 2003;5:242-248. (Pubitemid 36322252)
28. Toyoda H, Komurasaki T, Uchida D, et al. Epiregulin, a novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem 1995;270:7495-7500.
29. Kamata N, Fujimoto N, Tomonari M, et al. Immortalization of human dental papilla, dental pulp, periodontal ligament cells and gingival fibroblasts by telomerase reverse transcriptase. J Oral Pathol Med 2004;33:417-423. (Pubitemid 38988197)
30. Yamanouchi K, Satomura K, Gotoh Y, et al. Bone formation by transplanted human osteoblasts cultured within collagen sponge with dexamethasone in vitro. J Bone Miner Res 2001;16:857-867. (Pubitemid 32332295)
31. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Method 2001;25:402-408. (Pubitemid 34164012)
32. Yang YH, Dudoit S, Luu P, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002;30:e15.
33. Sleeman JP, Kondo K, Moll J, et al. Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44. J Biol Chem 1997;12:31837-31844. (Pubitemid 28013335)
34. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007;26:3291-3310. (Pubitemid 46763022)
35. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;16:1821-1828.
36. Noble PW. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 2002;21:25-29. (Pubitemid 34100819)
37. Pujana MA, Han JD, Starita LM, et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet 2007;39:1338-1349. (Pubitemid 350035000)
38. Kufer TA, Silljé HH, Kö rner R, et al. Human TPX2 is required for targeting Aurora-A kinase to the spindle. J Cell Biol 2002;158: 617-623. (Pubitemid 34920101)
39. Normanno N, De Luca A, Bianco C, et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 2006;366:2-16. (Pubitemid 43199589)
40. Bourguignon LY, Gilad E, Brightman A, et al. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem 2006;281:14026-14040. (Pubitemid 43848329)
41. Nakayama K, Tamura Y, Suzawa M, et al. Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cells. J Bone Miner Res 2003;18:827-835. (Pubitemid 37294965)
42. Higuchi C, Myoui A, Hashimoto N, et al. Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix. J Bone Miner Res 2002;17:1785-1794.
43. Schindeler A, Little DG. Ras-MAPK signaling in osteogenic differentiation: friend or foe? J Bone Miner Res 2006;21:1331-1338. (Pubitemid 44300039)